Suppr超能文献

MIR210HG 通过 miR-125b-5p/HK2/PKM2 轴调节胰腺癌细胞的糖酵解、增殖和转移。

MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis.

机构信息

Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.

Shanghai Institution of Medical Imaging, Shanghai, China.

出版信息

RNA Biol. 2021 Dec;18(12):2513-2530. doi: 10.1080/15476286.2021.1930755. Epub 2021 Jun 10.

Abstract

Pancreatic cancer has the worst prognosis of all common cancers. Pancreatic cancer cells have a metabolic advantage due to their swiftly adaptive responses to hypoxic and low-nutrient medium. This advantage contributes to the aggressivity of pancreatic cancer. In this study, lncRNA MIR210HG was abnormally upregulated within pancreatic cancer. It acted as a key oncogenic regulator of pancreatic cancer aggressiveness and glycolysis. Knockdown of MIR210HG significantly inhibited the aggressive phenotype of pancreatic cancer cells and inhibited the growth of xenograft tumours. More importantly, MIR210HG knockdown inhibited pancreatic cancer cell glycolysis via regulating the glycolysis-related hexokinase 2 (HK2) and Pyruvate kinase muscle isozyme M2 (PKM2) expression. Compared with the MIR210HG knockdown group, miR-125b-5p inhibition promoted the aggressive phenotypes and glycolysis of pancreatic cancer cells. Furthermore, the effects of MIR210HG knockdown on HK2 and PKM2 expression, pancreatic cancer cell aggressive phenotypes, and glycolysis were significantly reversed by miR-125b-5p inhibition. In tissue samples, MIR210HG expression was negatively correlated with miR-125b-5p levels and positively correlated with HK2 and PKM2 expression. miR-125b-5p expression was negatively correlated with HK2 and PKM2 expression. In conclusion, MIR210HG affected the phenotypes of pancreatic cancer cells, including proliferation, invasion, migration, and glycolysis, via modulating the miR-125b-5p/HK2/PKM2 axis.

摘要

胰腺癌是所有常见癌症中预后最差的一种。由于胰腺癌细胞能够迅速适应缺氧和低营养环境,因此具有代谢优势。这种优势有助于胰腺癌的侵袭性。在这项研究中,lncRNA MIR210HG 在胰腺癌中异常上调。它作为胰腺癌侵袭性和糖酵解的关键致癌调节剂发挥作用。MIR210HG 的敲低显著抑制了胰腺癌细胞的侵袭表型,并抑制了异种移植瘤的生长。更重要的是,MIR210HG 的敲低通过调节糖酵解相关的己糖激酶 2(HK2)和丙酮酸激酶肌肉同工酶 M2(PKM2)表达来抑制胰腺癌细胞的糖酵解。与 MIR210HG 敲低组相比,miR-125b-5p 的抑制促进了胰腺癌细胞的侵袭表型和糖酵解。此外,MIR210HG 敲低对 HK2 和 PKM2 表达、胰腺癌细胞侵袭表型和糖酵解的影响,通过 miR-125b-5p 的抑制显著逆转。在组织样本中,MIR210HG 的表达与 miR-125b-5p 的水平呈负相关,与 HK2 和 PKM2 的表达呈正相关。miR-125b-5p 的表达与 HK2 和 PKM2 的表达呈负相关。总之,MIR210HG 通过调节 miR-125b-5p/HK2/PKM2 轴影响胰腺癌细胞的表型,包括增殖、侵袭、迁移和糖酵解。

相似文献

1
MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis.
RNA Biol. 2021 Dec;18(12):2513-2530. doi: 10.1080/15476286.2021.1930755. Epub 2021 Jun 10.
3
miR-625-5p/PKM2 negatively regulates melanoma glycolysis state.
J Cell Biochem. 2019 Mar;120(3):2964-2972. doi: 10.1002/jcb.26917. Epub 2018 Nov 30.
4
MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
Biomed Pharmacother. 2018 Jul;103:1194-1201. doi: 10.1016/j.biopha.2018.04.098. Epub 2018 May 7.
5
Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Mol Cell Biochem. 2020 Nov;474(1-2):147-158. doi: 10.1007/s11010-020-03840-5. Epub 2020 Aug 1.
6
MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
Cell Prolif. 2018 Dec;51(6):e12510. doi: 10.1111/cpr.12510. Epub 2018 Aug 13.
8
LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
Biomed Pharmacother. 2019 Sep;117:109069. doi: 10.1016/j.biopha.2019.109069. Epub 2019 Jun 7.
10
Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
Biomed Pharmacother. 2018 Nov;107:1692-1704. doi: 10.1016/j.biopha.2018.07.071. Epub 2018 Sep 8.

引用本文的文献

1
PKM2-driven metabolic reprogramming in digestive system tumors: mechanisms, therapeutic advances, and clinical challenges.
Front Immunol. 2025 Aug 6;16:1634786. doi: 10.3389/fimmu.2025.1634786. eCollection 2025.
2
Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives.
Front Immunol. 2025 Jun 24;16:1586959. doi: 10.3389/fimmu.2025.1586959. eCollection 2025.
3
Decoding the pancreatic cancer microenvironment: The multifaceted regulation of microRNAs.
Clin Transl Med. 2025 Jul;15(7):e70354. doi: 10.1002/ctm2.70354.
4
The Role of HK2 in Tumorigenesis and Development: Potential for Targeted Therapy with Natural Products.
Int J Med Sci. 2025 Jan 21;22(4):790-805. doi: 10.7150/ijms.105553. eCollection 2025.
5
Autophagy-related long non-coding RNA MIR210HG plays a therapeutic role in hepatocellular carcinoma.
Discov Oncol. 2025 Jan 21;16(1):75. doi: 10.1007/s12672-025-01765-3.
7
LncRNA promotes prostate cancer progression by regulating the miR-512-3p/HK-2 axis.
Asian J Urol. 2024 Oct;11(4):575-585. doi: 10.1016/j.ajur.2024.01.007. Epub 2024 Feb 2.
8
Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response.
Noncoding RNA Res. 2024 Sep 11;10:98-115. doi: 10.1016/j.ncrna.2024.09.006. eCollection 2025 Feb.
10
lncRNA Biomarkers of Glioblastoma Multiforme.
Biomedicines. 2024 Apr 23;12(5):932. doi: 10.3390/biomedicines12050932.

本文引用的文献

2
Non-coding RNAs: the new central dogma of cancer biology.
Sci China Life Sci. 2021 Jan;64(1):22-50. doi: 10.1007/s11427-020-1700-9. Epub 2020 Sep 11.
3
Future directions of neoadjuvant therapy in pancreatic cancer.
Oncoscience. 2020 May 14;7(7-8):44-46. doi: 10.18632/oncoscience.506. eCollection 2020 Jul.
4
Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer.
Cancer Cell Int. 2020 Jun 24;20:273. doi: 10.1186/s12935-020-01370-0. eCollection 2020.
5
Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma.
Cancer Cell Int. 2020 Jun 11;20:231. doi: 10.1186/s12935-020-01243-6. eCollection 2020.
6
Hypoxia-related long noncoding RNAs are associated with varicocele-related male infertility.
PLoS One. 2020 Apr 30;15(4):e0232357. doi: 10.1371/journal.pone.0232357. eCollection 2020.
7
To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
J Cell Mol Med. 2020 May;24(9):5375-5386. doi: 10.1111/jcmm.15193. Epub 2020 Mar 31.
8
MIR210HG promotes cell proliferation and invasion by regulating miR-503-5p/TRAF4 axis in cervical cancer.
Aging (Albany NY). 2020 Feb 21;12(4):3205-3217. doi: 10.18632/aging.102799.
9
Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
J Recept Signal Transduct Res. 2019 Oct-Dec;39(5-6):399-406. doi: 10.1080/10799893.2019.1683863. Epub 2019 Dec 26.
10
The Role of Non-coding RNAs in Oncology.
Cell. 2019 Nov 14;179(5):1033-1055. doi: 10.1016/j.cell.2019.10.017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验